Agilon Health（NYSE:AGL）报告每股收益为-0.26美元，低于分析师预期的-0.23美元，差距为13.04%。公司报告季度销售额为15.2亿美元，符合分析师预期。这比去年同期的10.6亿美元增长了43.94%。
以上内容来自Benzinga Earnings专栏，原文如下：
Agilon Health (NYSE:AGL) reported quarterly losses of $(0.26) per share which missed the analyst consensus estimate of $(0.23) by 13.04 percent. The company reported quarterly sales of $1.52 billion which met the analyst consensus estimate. This is a 43.94 percent increase over sales of $1.06 billion the same period last year.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.